(Last updated : 2026-09-01 09:41:48)
  HORIUCHI Toshihide
   Department   School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine  
   Position   Clinical Assistant Professor
■ Published papers
1. Other  Prognostic impact of early C-reactive proteindynamics in advanced renal cell carcinoma treated with immune checkpoint inhibitor combinations. 2026/05 Link
2. Other  Safety and efficacy of enfortumab vedotin for metastatic urothelial carcinoma in over 80 years old patients: Multi-center retrospective study in JAPAN. 2026/05 Link
3. Original article  Renal function with enfortumab vedotin in metastatic urothelial carcinoma: A multicenter retrospective study in Japan. 2025/12
4. Original article  Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma. 2025/10
5. Original article  A case of complete remission of bilateral upper tract carcinoma in situ following retrograde bacillus calmette–guérin (BCG) instillation via open- ended ureteral catheters after failure using Double- J stents. 2025/09/17
Display all(17)
■ Academic conference presentation
1. Prognostic impact of early C-reactive protein dynamics in advanced renal cell carcinoma treated with immune checkpoint inhibitor combinations. (ポスター掲示,一般) 2026/05/18
2. Safety and efficacy of enfortumab vedotin for metastatic urothelial carcinoma in over 80 years old patients: Multi-center retrospective study in JAPAN (ポスター掲示,一般) 2026/05/16
3. Evaluation of PSA levels after prostatic urethral lift. (口頭,一般) 2026/04/24
4. Association between obesity and adverse events in nivolumab plus cabozantinib combination therapy for metastatic renal cell carcinoma. (口頭,一般) 2026/04/23
5. Prognostic impact of early C-reactive protein dynamics in advanced renal cell carcinoma treated with immune checkpoint inhibitor combinations. (口頭,一般) 2026/04/23
Display all(14)